272 related articles for article (PubMed ID: 30103666)
1. Infantile Myofibromatosis With Intracranial Extradural Involvement and PDGFRB Mutation: A Case Report and Review of the Literature.
Al Qawahmed R; Sawyer SL; Vassilyadi M; Qin W; Boycott KM; Michaud J
Pediatr Dev Pathol; 2019; 22(3):258-264. PubMed ID: 30103666
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of infantile myofibromatosis includes both non-penetrance and adult recurrence.
Murray N; Hanna B; Graf N; Fu H; Mylène V; Campeau PM; Ronan A
Eur J Med Genet; 2017 Jul; 60(7):353-358. PubMed ID: 28286173
[TBL] [Abstract][Full Text] [Related]
3. PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis.
Arts FA; Sciot R; Brichard B; Renard M; de Rocca Serra A; Dachy G; Noël LA; Velghe AI; Galant C; Debiec-Rychter M; Van Damme A; Vikkula M; Helaers R; Limaye N; Poirel HA; Demoulin JB
Hum Mol Genet; 2017 May; 26(10):1801-1810. PubMed ID: 28334876
[TBL] [Abstract][Full Text] [Related]
4. Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene.
Mudry P; Slaby O; Neradil J; Soukalova J; Melicharkova K; Rohleder O; Jezova M; Seehofnerova A; Michu E; Veselska R; Sterba J
BMC Cancer; 2017 Feb; 17(1):119. PubMed ID: 28183292
[TBL] [Abstract][Full Text] [Related]
5. PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.
Arts FA; Chand D; Pecquet C; Velghe AI; Constantinescu S; Hallberg B; Demoulin JB
Oncogene; 2016 Jun; 35(25):3239-48. PubMed ID: 26455322
[TBL] [Abstract][Full Text] [Related]
6. Modulation of expressivity in PDGFRB-related infantile myofibromatosis: a role for PTPRG?
Linhares ND; Freire MC; Cardenas RG; Bahia M; Puzenat E; Aubin F; Pena SD
Genet Mol Res; 2014 Aug; 13(3):6287-92. PubMed ID: 25158255
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and Myopericytomas.
Agaimy A; Bieg M; Michal M; Geddert H; Märkl B; Seitz J; Moskalev EA; Schlesner M; Metzler M; Hartmann A; Wiemann S; Michal M; Mentzel T; Haller F
Am J Surg Pathol; 2017 Feb; 41(2):195-203. PubMed ID: 27776010
[TBL] [Abstract][Full Text] [Related]
8. Myopericytomatosis: Clinicopathologic Analysis of 11 Cases With Molecular Identification of Recurrent PDGFRB Alterations in Myopericytomatosis and Myopericytoma.
Hung YP; Fletcher CDM
Am J Surg Pathol; 2017 Aug; 41(8):1034-1044. PubMed ID: 28505006
[TBL] [Abstract][Full Text] [Related]
9. [Myofibroma/myofibromatosis: a clinicopathologic analysis of 9 cases].
Fu Y; Guan WY; Wu HY; Wu HY; Fan ZW; Ye Q; Meng FQ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):45-50. PubMed ID: 29325250
[No Abstract] [Full Text] [Related]
10. A recurrent PDGFRB mutation causes familial infantile myofibromatosis.
Cheung YH; Gayden T; Campeau PM; LeDuc CA; Russo D; Nguyen VH; Guo J; Qi M; Guan Y; Albrecht S; Moroz B; Eldin KW; Lu JT; Schwartzentruber J; Malkin D; Berghuis AM; Emil S; Gibbs RA; Burk DL; Vanstone M; Lee BH; Orchard D; Boycott KM; Chung WK; Jabado N
Am J Hum Genet; 2013 Jun; 92(6):996-1000. PubMed ID: 23731537
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous PDGFRB Mutation in a Three-generation Family with Autosomal Dominant Infantile Myofibromatosis.
Lepelletier C; Al-Sarraj Y; Bodemer C; Shaath H; Fraitag S; Kambouris M; Hamel-Teillac D; El Shanti H; Hadj-Rabia S
Acta Derm Venereol; 2017 Jul; 97(7):858-859. PubMed ID: 28417142
[No Abstract] [Full Text] [Related]
12. Novel
Hassan M; Butler E; Wilson R; Roy A; Zheng Y; Liem P; Rakheja D; Pavlick D; Young LL; Rosenzweig M; Erlich R; Ali SM; Leavey PJ; Parsons DW; Skapek SX; Laetsch TW
Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31645346
[TBL] [Abstract][Full Text] [Related]
13. [Sporadic infantile myofibromatosis: Mutations with PDGFRB gain-of-function].
Dereure O
Ann Dermatol Venereol; 2017; 144(8-9):574-575. PubMed ID: 28756885
[No Abstract] [Full Text] [Related]
14. PDGRFB mutation-associated myofibromatosis: Response to targeted therapy with imatinib.
Weller JM; Keil VC; Gielen GH; Herrlinger U; Schäfer N
Am J Med Genet A; 2019 Sep; 179(9):1895-1897. PubMed ID: 31291054
[TBL] [Abstract][Full Text] [Related]
15. Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a
Sramek M; Neradil J; Macigova P; Mudry P; Polaskova K; Slaby O; Noskova H; Sterba J; Veselska R
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200486
[TBL] [Abstract][Full Text] [Related]
16. Intracranial Infantile Myofibromatosis Mimicking Malignant Brain Tumor: A Case Report and Literature Review.
Inoue M; Tanaka S; Nakatomi H; Takayanagi S; Takahashi M; Tanaka M; Momose T; Mukasa A; Saito N
World Neurosurg; 2016 Sep; 93():487.e15-20. PubMed ID: 27373934
[TBL] [Abstract][Full Text] [Related]
17. Unusual Presentation of Infantile Myofibroma in the Deep Palm of a Child: A Case Report and Discussion of the Differential Diagnosis.
Brown MS; Heider A; Chung KC
J Hand Surg Am; 2017 Mar; 42(3):e193-e198. PubMed ID: 27955965
[TBL] [Abstract][Full Text] [Related]
18. [Autosomal dominant (familial) infantile myofibromatosis: The causative role of mutations in PDGFRB and NOTCH3].
Dereure O
Ann Dermatol Venereol; 2013 Dec; 140(12):833-4. PubMed ID: 24315235
[No Abstract] [Full Text] [Related]
19. Prenatal genetic diagnosis of disseminated infantile myofibromatosis: a case report and literature review.
Lü Y; Jiang Y; Wu H; Qi Q; Zhou X; Guo Q; Hao N; Liu J; Meng H
BMC Med Genomics; 2023 Aug; 16(1):185. PubMed ID: 37568122
[TBL] [Abstract][Full Text] [Related]
20. A novel de novo PDGFRB variant in a child with severe cerebral malformations, intracerebral calcifications, and infantile myofibromatosis.
Guimier A; Gordon CT; Hully M; Blauwblomme T; Minard-Colin V; Bole-Feysot C; Nitschké P; Oufadem M; Boddaert N; Sarnacki S; Amiel J
Am J Med Genet A; 2019 Jul; 179(7):1304-1309. PubMed ID: 31004414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]